Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Spero Therapeutics Inc
(NQ:
SPRO
)
1.370
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
254,910
Open
1.400
Bid (Size)
1.360 (20)
Ask (Size)
1.400 (5)
Prev. Close
1.370
Today's Range
1.340 - 1.400
52wk Range
0.9900 - 1.890
Shares Outstanding
52,571,813
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SPRO Stock Earnings: Spero Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 05, 2024
SPRO stock results show that Spero Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
3 Micro-Cap Moonshots for Fearless Investors
July 08, 2024
Investors should know the risks of micro-cap stocks before looking into these three high-potential companies with low prices.
Via
InvestorPlace
Performance
YTD
-9.87%
-9.87%
1 Month
-2.84%
-2.84%
3 Month
-3.52%
-3.52%
6 Month
-16.97%
-16.97%
1 Year
-4.86%
-4.86%
More News
Read More
SPRO Stock Earnings: Spero Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
Via
InvestorPlace
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
March 14, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 14, 2024
Via
InvestorPlace
Recap: Spero Therapeutics Q4 Earnings
March 13, 2024
Via
Benzinga
Earnings Outlook For Spero Therapeutics
March 12, 2024
Via
Benzinga
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Via
Benzinga
5 Value Stocks In The Healthcare Sector
December 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 14, 2023
Via
Benzinga
Recap: Spero Therapeutics Q3 Earnings
November 13, 2023
Via
Benzinga
Earnings Outlook For Spero Therapeutics
November 10, 2023
Via
Benzinga
4 Analysts Have This to Say About Spero Therapeutics
September 05, 2023
Via
Benzinga
Earnings Scheduled For March 13, 2024
March 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 13, 2023
Via
Benzinga
Spero Therapeutics's Earnings: A Preview
August 09, 2023
Via
Benzinga
Recap: Spero Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
Spero Therapeutics's Earnings Outlook
May 10, 2023
Via
Benzinga
Earnings Scheduled For November 13, 2023
November 13, 2023
Via
Benzinga
SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
November 02, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Overview Of Value Stocks In The Healthcare Sector
September 18, 2023
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Spero Therapeutics: Here's What You Need To Know
August 14, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 31, 2023
Via
InvestorPlace
Earnings Scheduled For August 10, 2023
August 10, 2023
Via
Benzinga
Earnings Scheduled For May 11, 2023
May 11, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.